Status:
COMPLETED
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Advanced Ovarian Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
To compare dose-dense chemotherapy with intraperitoneal chemotherapy in patients with advanced stage ovarian cancer.
Detailed Description
Women aged 20 and above, diagnosed with advanced stage ovarian cancer (FIGO stage II\~IV), who had received debulking surgery, followed by adjuvant chemotherapy (either dose-dense or intraperitoneal) ...
Eligibility Criteria
Inclusion
- Women with FIGO stage II\~IV ovarian cancer
- At least one cycle of intravenous dose-dense or intraperitoneal chemotherapy had been administered as the front-line chemotherapy.
Exclusion
- none
Key Trial Info
Start Date :
October 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04135521
Start Date
October 28 2019
End Date
March 31 2020
Last Update
June 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050